Simple Renal Caliceal Stones. Calculus of kidney
Conditions
Interventions
Intervention 1: Intervention group: Controlled hypotensive anesthesia will be induced by injection of 5 mg/mL Labetalol dissolved in 0.9% normal saline to maintain MAP at approximately 60 mmHg. Interv
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age between 18 and 60 years Patients with functionally healthy kidneys Patients with simple renal caliceal stones candidate for PCNL surgery Patients who agree to participate in this trial will provide written informed consent.
Exclusion criteria
Exclusion criteria: Age above 60 years Patients reported a history of hypertension, obstructive pulmonary disease, chronickidney disease, liver disease, cardiovascular disease (especially severe sinusbradycardia), and patients with high creatinine levels Patients reported a history of diabetes mellitus, major neurologic conditions such asstroke or multiple sclerosis, and cardiovascular problems such as heart failure. Patients with large and complex stones. Not eligible to participate in this trial as a decision of the researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operative blood loss. Timepoint: During PCNL surgery. Method of measurement: Operative blood loss was calculated by the volume of blood recovered from the suction bottle and visual estimation from the sponge and lap counts.;Hematocrit drop. Timepoint: Before and after PCNL surgery. Method of measurement: Using measurement in patient lab testing. | — |
Secondary
| Measure | Time frame |
|---|---|
| Operative time. Timepoint: From the beginning of the needle to the kidney until the end of the operation. Method of measurement: Record by minutes.;Stone free rate. Timepoint: Before and after PCNL surgery. Method of measurement: CT scan. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Masjedi
Shiraz University of Medical Sciences
Outcome results
None listed